Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA)

CUSIP: 05153U107

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
-1,519,014
SEC-reported price per share
$5.45
Number of holders
116
Value change
-$8,935,762
Number of buys
50
Number of sells
46
Security identity 1 source field
Shares outstanding
96,296,293

Security key

05153U107

Report period

Q4 2025

Institutions

116

Top holders

10

Ownership snapshot

Top reported holders of AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SUVRETTA CAPITAL MANAGEME...
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 7.6% 13D/G row: SUVRETTA CAPITAL MANAGEMENT, LLC Showing 1-6 of 15 holder rows.

Quick read

SUVRETTA CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 7.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5
SUVRETTA CAPITAL MANAGEMENT, LLC 7.6%
Long Focus Capital Management, LLC 6.6%
Frazier Life Sciences Public Fund... 6.3%
BlackRock, Inc. 5.4%
Matrix Capital Management Company... 7.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SUVRETTA CAPITAL MANAGEMENT, LLC
13D/G 13F
Company
7.6%
$30,091,360
4,701,775 shares
+$10,524,518 30 Jun 2025
Long Focus Capital Management, LLC
13F 13D/G
Company
6.6%
from 13D/G
$28,549,017
4,619,582 shares
30 Sep 2025
Frazier Life Sciences Public Fund, L.P.
13D/G
6.3%
$20,523,185
4,032,060 shares
+$4,675,216 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
5.4%
from 13D/G
$21,045,849
3,405,477 shares
30 Sep 2025
Matrix Capital Management Company, LP
13F
Company
13F
7.2%
$42,783,337
6,922,870 shares
30 Sep 2025
Frazier Life Sciences Management, L.P.
13F
Company
13F
5.3%
$31,518,000
5,100,000 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
116
Shares
50,234,935
Rows available
116
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
106
Q4 2025 holders
116
Holder diff
10
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .